The bug, the burden, and the biology: beyond host-centric phenotyping in sepsis

Georgios D Kitsios1,2, Rebecca M Baron3

  • 1Division of Pulmonary, Allergy, Critical Care and Sleep Medicine and.

Insights

Pathogen characteristics, like E. coli, independently influence sepsis subphenotypes, impacting treatment effectiveness. Understanding the interplay between host and pathogen is crucial for precision critical care medicine.

Area of Science:

  • Critical care medicine
  • Infectious diseases
  • Immunology

Background:

  • Sepsis subtyping traditionally focuses on host responses (hyperinflammatory vs. hypoinflammatory).
  • Previous models overlooked the independent contribution of infectious agents to sepsis phenotypes.

Purpose of the Study:

  • To investigate the independent role of pathogen characteristics in determining sepsis subphenotypes.
  • To explore how pathogen-host interactions influence clinical outcomes and treatment efficacy.

Main Methods:

  • Analysis of host biomarkers and clinical data alongside pathogen identification.
  • Utilized animal models to establish causality.
  • Reanalyzed observational cohort and clinical trial data.

Main Results:

  • Enterobacterales infections, especially E. coli, are linked to hyperinflammatory sepsis subphenotypes, irrespective of illness severity.
  • Bacterial burden, barrier breach, and pathogen-associated molecular patterns affect sepsis classification.
  • Lactate clearance and polymyxin B hemoadsorption efficacy vary based on sepsis subphenotype and pathogen.

Conclusions:

  • Pathogen factors significantly contribute to sepsis subphenotypes, challenging the host-centric view.
  • Integrative host-pathogen phenotyping is essential for advancing precision medicine in critical illness.
  • Tailoring treatments based on both host and pathogen profiles can improve patient outcomes.

Related Concept Videos

Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.6K
Microbial Interactions: Parasitism01:22

Microbial Interactions: Parasitism

Parasitism is a form of microbial interaction in which parasitic microbes exploit a host organism for nutrients and shelter, often at the host's expense. Unlike mutualistic relationships, where both organisms benefit, parasitism benefits only the parasite and harms the host.Classification of ParasitesMicrobial parasites are broadly classified based on their location relative to the host.Ectoparasites remain on the host’s surface, such as the skin or outer tissues, drawing nutrients...
108
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
77
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24